Anti-Cancer Agents in Medicinal Chemistry
Title: Editorial [Hot Topic:Preamble: CDC25 Phosphatases in Cancer and CDC25 Inhibitors (Guest Editor: Gregoire Pierre Prevost)]
Volume: 8 Issue: 8
Author(s): Gregoire Pierre Prevost
Affiliation:
Export Options
About this article
Cite this article as:
Prevost Pierre Gregoire, Editorial [Hot Topic:Preamble: CDC25 Phosphatases in Cancer and CDC25 Inhibitors (Guest Editor: Gregoire Pierre Prevost)], Anti-Cancer Agents in Medicinal Chemistry 2008; 8 (8) . https://dx.doi.org/10.2174/187152008786847774
DOI https://dx.doi.org/10.2174/187152008786847774 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
15
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Effect of Safflower Oil on Concentration of Conjugated Linoleic Acid of Kefir Prepared by Low-fat Milk
Recent Patents on Food, Nutrition & Agriculture Natural Cyclic Peptides as Clinical and Future Therapeutics
Current Organic Chemistry Chemical Constituents and Bioactivities of the Plants of Genus Flemingia Roxb. et Ait. (Leguminosae)
Combinatorial Chemistry & High Throughput Screening Isolation of Secreted microRNAs (miRNAs) from Cell-conditioned Media
MicroRNA Application of Genomics in the Prevention, Treatment and Management of Achilles Tendinopathy and Anterior Cruciate Ligament Ruptures
Recent Patents on DNA & Gene Sequences Tyrosinase Expression as a Molecular Marker for Investigating the Presence of Circulating Tumor Cells in Melanoma Patients
Current Cancer Drug Targets A Fluorescent Alkyllysophospholipid Analog Exhibits Selective Cytotoxicity Against the Hormone-Insensitive Prostate Cancer Cell Line PC3
Anti-Cancer Agents in Medicinal Chemistry Metallic Nanoparticles as SERS Agents for Biomolecular Imaging
Current Pharmaceutical Biotechnology Identification of Functional Peptides from Natural and Synthetic Products on Their Anticancer Activities by Tumor Targeting
Current Medicinal Chemistry A hypothesis for the role of RECK in angiogenesis
Current Vascular Pharmacology Anaplastic Lymphoma Kinase Inhibitors in Non-Small Cell Lung Cancer
Current Drug Targets Fluorescein-labeled Bacitracin and Daptomycin Conjugates: Synthesis, Fluorescence Imaging and Evaluation
Medicinal Chemistry Perspectives on New Synthetic Curcumin Analogs and their Potential Anticancer Properties
Current Pharmaceutical Design Redox Homeostasis and Epigenetics in Non-alcoholic Fatty Liver Disease (NAFLD)
Current Pharmaceutical Design Preparation and Physicochemical Characterization of Glyceryl Monoolein Bearing Cubosomes to Improve Vitamin E delivery into the Skin: A Proposal for Skin Cancer Prevention
Drug Delivery Letters The Role of Insulin Resistance and Hyperinsulinemia in Cancer Causation
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Dysfunctional Mechanism of Liver Cancer Mediated by Transcription Factor and Non-coding RNA
Current Bioinformatics Meet Our Editorial Board Member
Current Cancer Drug Targets A Review on the Development in the Field of NIDDM based Thiazolidinedione PPARγ Agonists
Mini-Reviews in Medicinal Chemistry